Who Paid My Doc
Jose Cardona
General Practice Miami, FL Medical Doctor
NPI 1932107695 CMS profile 1129903
7951 Sw 40Th St, Ste 212, Miami, FL 33155
General payments
$14,931
Research payments
$149,461
Ownership & investment interest
$0
Research they led as principal investigator
$70,986,560
Through program year 2025, Jose Cardona of Miami, FL is reported in the CMS Open Payments database as having received $14,931 across 94 general payments and $149,461 in research payments paid to them. Separately, studies naming them as principal investigator received $70,986,560 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of General Practice profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
13 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,333 | 7 | |
| 2025 | Research | $3,200 | 1 | |
| 2024 | General | $3,615 | 26 | |
| 2024 | Research | $4,994 | 11 | |
| 2023 | General | $4,372 | 23 | |
| 2023 | Research | $16,340 | 5 | |
| 2022 | General | $360 | 8 | |
| 2022 | Research | $94,231 | 11 | |
| 2021 | General | $20 | 1 | |
| 2020 | General | $1,000 | 1 | |
| 2020 | Research | $27,950 | 3 | |
| 2019 | General | $4,230 | 28 | |
| 2019 | Research | $2,746 | 14 |
Beside peers
- Jose Cardona
- General Practice median
- Middle half of General Practice
- National median
In program year 2025, general payments to Jose Cardona were reported at $1,333. Among 4,774 General Practice profiles paid that year, the median was $106 and the middle half received between $35 and $292.
Show as a table
| Year | Jose Cardona | General Practice median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $4,230 | $107 | $37–$285 | $163 |
| 2020 | $1,000 | $75 | $25–$213 | $114 |
| 2021 | $20 | $93 | $30–$272 | $132 |
| 2022 | $360 | $103 | $36–$279 | $149 |
| 2023 | $4,372 | $106 | $34–$276 | $160 |
| 2024 | $3,615 | $114 | $39–$290 | $164 |
| 2025 | $1,333 | $106 | $35–$292 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
139 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other General Practice in Florida
Caley Castelein
General Practice · Miami Beach, FL
Robert Althar
General Practice · Pensacola, FL
Florencia Ziemke
General Practice · West Palm Beach, FL
Ausberto Hidalgo
General Practice · Pembroke Pines, FL
Ernesto Lamadrid
General Practice · Gainesville, FL
Idalia Acosta
General Practice · Miami, FL
Related records
General Practice in Florida
Practitioners in the same specialty and state, ranked by reported value.
All General Practice
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.